CN107073049B - 益生菌和益生元组合物 - Google Patents

益生菌和益生元组合物 Download PDF

Info

Publication number
CN107073049B
CN107073049B CN201580057157.0A CN201580057157A CN107073049B CN 107073049 B CN107073049 B CN 107073049B CN 201580057157 A CN201580057157 A CN 201580057157A CN 107073049 B CN107073049 B CN 107073049B
Authority
CN
China
Prior art keywords
composition
strain
strains
inhibition
zone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201580057157.0A
Other languages
English (en)
Chinese (zh)
Other versions
CN107073049A (zh
Inventor
佩德罗·米格尔·鲁维奥·尼斯特
安娜·玛利亚·卡瓦哈尔·乌鲁埃尼亚
玛尔塔·加西亚·迪兹
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AQUILON CYL SANIDAD ANIMAL
University of Leon
Original Assignee
AQUILON CYL SANIDAD ANIMAL
University of Leon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AQUILON CYL SANIDAD ANIMAL, University of Leon filed Critical AQUILON CYL SANIDAD ANIMAL
Publication of CN107073049A publication Critical patent/CN107073049A/zh
Application granted granted Critical
Publication of CN107073049B publication Critical patent/CN107073049B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/25—Lactobacillus plantarum
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN201580057157.0A 2014-10-21 2015-10-21 益生菌和益生元组合物 Active CN107073049B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14382412.6 2014-10-21
EP14382412 2014-10-21
PCT/EP2015/074375 WO2016062771A1 (en) 2014-10-21 2015-10-21 Probiotic and prebiotic compositions

Publications (2)

Publication Number Publication Date
CN107073049A CN107073049A (zh) 2017-08-18
CN107073049B true CN107073049B (zh) 2021-12-14

Family

ID=51846603

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201580057157.0A Active CN107073049B (zh) 2014-10-21 2015-10-21 益生菌和益生元组合物

Country Status (14)

Country Link
US (1) US10179153B2 (enExample)
EP (1) EP3209307B1 (enExample)
JP (1) JP6765370B2 (enExample)
KR (1) KR102517581B1 (enExample)
CN (1) CN107073049B (enExample)
AU (1) AU2015334989B2 (enExample)
BR (1) BR112017008184B1 (enExample)
CA (1) CA2965214C (enExample)
DK (1) DK3209307T3 (enExample)
ES (1) ES2936842T3 (enExample)
PH (1) PH12017500708A1 (enExample)
PL (1) PL3209307T3 (enExample)
RU (1) RU2741836C2 (enExample)
WO (1) WO2016062771A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10624934B2 (en) 2014-03-06 2020-04-21 Research Institute At Nationwide Children's Hospital Prebiotic formulations
EP3536168A3 (en) 2014-03-06 2019-10-16 The Research Institute at Nationwide Children's Hospital Probiotic formulations and methods for use
US11959125B2 (en) 2016-09-15 2024-04-16 Sun Genomics, Inc. Universal method for extracting nucleic acid molecules from a diverse population of one or more types of microbes in a sample
KR101851297B1 (ko) * 2017-02-13 2018-04-23 강원대학교 산학협력단 신규한 락토바실러스 루테리 균주 및 그 항균 용도
US20200113950A1 (en) * 2017-06-30 2020-04-16 The Rockefeller University Human microbiota derived N-acyl amides for the treatment of human disease
KR20190070457A (ko) 2017-12-13 2019-06-21 주식회사 오투파워 이산화염소를 포함하는 닭 대장균증 예방을 위한 음용수 첨가용 조성물
EP3870154A4 (en) 2018-10-22 2022-07-27 Research Institute at Nationwide Children's Hospital COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF ANTIBIOTIC-INDUCED PATHOLOGIES USING PROBIOTICS IN BIOFILM STATE
CN109385387B (zh) * 2018-12-28 2022-04-05 上海源耀农牧科技有限公司 一种抗tgev的罗伊氏乳杆菌及其应用
KR102978329B1 (ko) 2019-06-03 2026-06-17 더 리서치 인스티튜트 앳 네이션와이드 칠드런스 하스피탈 패혈증 및 괴사성 장염 유도된 신경발달 결핍의 예방을 위한 프리바이오틱 제형
CN112877231B (zh) * 2019-11-29 2023-06-23 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） 具有抑菌和抗氧化活性的乳酸菌及其应用
US20230158088A1 (en) * 2020-03-26 2023-05-25 Persephone Biosciences, Inc. Compositions for modulating gut microflora populations, enhancing drug potency and treating viral infections, and methods for making and using same
WO2021211620A1 (en) * 2020-04-13 2021-10-21 Sun Genomics, Inc. Method and system for detecting and treating exposure to an infectious pathogen
US12447182B2 (en) * 2020-06-10 2025-10-21 The Board Of Trustees Of The University Of Arkansas Swine origin probiotics that promote health and growth performance in pigs

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1997499A1 (en) * 2007-05-31 2008-12-03 Puleva Biotech, S.A. Mammalian milk microorganisms, compositions containing them and their use for the treatment of mastitis
WO2014049023A1 (en) * 2012-09-25 2014-04-03 Aquilon Cyl Sanidad Animal Probiotic and prebiotic compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1034788A1 (en) * 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactic acid bacteria strains capable of preventing diarrhea
CA2517245C (en) * 2003-02-28 2009-01-20 Mcgill University Cell and enzyme compositions for modulating bile acids, cholesterol and triglycerides
AU2003247193A1 (en) 2003-07-23 2005-02-04 M.D.Lab Corp. Acid tolerant probiotic lactobacillus plantarum probio-38 that can suppress the growth of pathogenic microorganism and tge coronavirus
KR100513168B1 (ko) * 2003-08-27 2005-09-07 주식회사 프로바이오닉 돼지 유행성 설사증 (PED) 코로나바이러스 및 유해 미생물 억제 활성을 가지는 신규 내 산성 엔테로코커스 훼카리스Probio-056 및 이를 함유하는 생균활성제
CA2783414A1 (en) * 2012-07-22 2014-01-22 Integral Medical Inc. Probiotic composition

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1997499A1 (en) * 2007-05-31 2008-12-03 Puleva Biotech, S.A. Mammalian milk microorganisms, compositions containing them and their use for the treatment of mastitis
WO2014049023A1 (en) * 2012-09-25 2014-04-03 Aquilon Cyl Sanidad Animal Probiotic and prebiotic compositions

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
bile tolerant lactobacillus reuteri isolated from pig feces inhibits enteric bacterial pathogens and porcine rotavirus;Byeong Joo Seo等;《Vet Res Commun》;20100416;323-333 *

Also Published As

Publication number Publication date
NZ730699A (en) 2024-04-26
CA2965214A1 (en) 2016-04-28
JP6765370B2 (ja) 2020-10-07
ES2936842T3 (es) 2023-03-22
RU2741836C2 (ru) 2021-01-29
BR112017008184B1 (pt) 2021-10-19
PH12017500708A1 (en) 2017-10-09
CN107073049A (zh) 2017-08-18
AU2015334989A1 (en) 2017-04-20
CA2965214C (en) 2022-01-11
RU2017113027A3 (enExample) 2019-05-29
AU2015334989B2 (en) 2020-10-08
US10179153B2 (en) 2019-01-15
PL3209307T3 (pl) 2023-05-22
WO2016062771A1 (en) 2016-04-28
EP3209307A1 (en) 2017-08-30
BR112017008184A2 (pt) 2017-12-26
RU2017113027A (ru) 2018-11-22
DK3209307T3 (da) 2023-01-09
EP3209307B1 (en) 2022-10-05
KR102517581B1 (ko) 2023-04-03
JP2017533197A (ja) 2017-11-09
US20170312321A1 (en) 2017-11-02
KR20170088847A (ko) 2017-08-02

Similar Documents

Publication Publication Date Title
EP3209307B1 (en) Probiotic and prebiotic compositions
EP2900805B1 (en) Probiotic and prebiotic compositions
JP2008538913A (ja) 動物用に適しているプロバイオティクス組成物
US9724373B2 (en) FOS-based prebiotic and bacterial-based probiotic
US10314869B2 (en) Probiotic pathogen inhibition composition and method
US9737576B2 (en) Dairy administered bacterial composition
US9724372B2 (en) Calf administered bacterial composition
US20210030822A1 (en) Probiotic pathogen inhibition composition and method
WO2024165889A1 (en) Psychobiotic probiotic for veterinary use
Kim Antimicrobial susceptibility profiles in E. coli populations from growing pigs following use of feed-based subtherapeutic antimicrobials or a competitive exclusion culture
Kantas et al. A feed additive containing Bacillus toyonensis in weaning piglets
JP2012180304A (ja) 鶏のカンピロバクター感染を制御するための飲料

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
TG01 Patent term adjustment

Free format text: NEW EXPIRY DATE: 20360216

TG01 Patent term adjustment